Literature DB >> 7452215

Neuropsychological deficits in Cushing's syndrome.

T B Whelan, D E Schteingart, M N Starkman, A Smith.   

Abstract

In contrast to well documented reports of medical symptoms in Cushing's syndrome (an endocrine disorder with the hallmark of corticoid overproduction), vague and infrequent references to associated mental changes reflect the subjective nature of previous clinical studies of psychological symptoms. This report presents neuropsychological test findings of 35 Cushing's syndrome patients before initiation of medical therapy, and documents the frequency, nature, and severity of deficits. Performances on the Michigan Neuropsychological Test Battery revealed equivocal or no signs of neuropsychological deficits in 13 patients. Ten other patients had few and mild deficits, eight had moderate and more frequent signs of impairment, and four had frequent and marked deficits in language and nonlanguage tests of higher (cognitive) and/or lower (sensory and/or motor) level cerebral functions. The findings thus indicate varying degrees of diffuse bilateral cerebral dysfunction in two thirds of this population. Impairment was more frequent and severe in nonverbal visual-ideational and visual memory functions. This pattern of deficits is similar to that in patients with other types of diffuse bilateral neuropathological processes such as toxicity, anoxia, and infectious cerebral disorders.

Entities:  

Mesh:

Year:  1980        PMID: 7452215     DOI: 10.1097/00005053-198012000-00008

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  9 in total

1.  Structural and Functional Consequences of Hypercortisolism on Brain: Are the Brain and Psycho-neuro-cognitive Manifestations Reversible?

Authors:  Mahendra Kumar Garg; Madhukar Mittal
Journal:  Indian J Endocrinol Metab       Date:  2021-01-12

Review 2.  Hormones and cognition: current concepts and issues in neuropsychology.

Authors:  D M Erlanger; K C Kutner; A R Jacobs
Journal:  Neuropsychol Rev       Date:  1999-12       Impact factor: 7.444

3.  Cross-sectional and 35-year longitudinal assessment of salivary cortisol and cognitive functioning: the Vietnam Era twin study of aging.

Authors:  Carol E Franz; Robert C O'Brien; Richard L Hauger; Sally P Mendoza; Matthew S Panizzon; Elizabeth Prom-Wormley; Lindon J Eaves; Kristen Jacobson; Michael J Lyons; Sonia Lupien; Dirk Hellhammer; Hong Xian; William S Kremen
Journal:  Psychoneuroendocrinology       Date:  2011-02-03       Impact factor: 4.905

4.  Predictive factors for neurocognitive function and Quality of Life after surgical treatment for Cushing's disease and acromegaly.

Authors:  T Psaras; M Milian; V Hattermann; B E Will; M Tatagiba; J Honegger
Journal:  J Endocrinol Invest       Date:  2010-11-08       Impact factor: 4.256

Review 5.  Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits.

Authors:  J Raber
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

6.  Cases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome.

Authors:  Margaret F Keil; Alan Zametkin; Celia Ryder; Maya Lodish; Constantine A Stratakis
Journal:  Pediatrics       Date:  2016-03-29       Impact factor: 7.124

Review 7.  Quality of life and other outcomes in children treated for Cushing syndrome.

Authors:  Margaret F Keil
Journal:  J Clin Endocrinol Metab       Date:  2013-05-02       Impact factor: 5.958

Review 8.  Neuropsychiatric disorders in Cushing's syndrome.

Authors:  Rosario Pivonello; Chiara Simeoli; Maria Cristina De Martino; Alessia Cozzolino; Monica De Leo; Davide Iacuaniello; Claudia Pivonello; Mariarosaria Negri; Maria Teresa Pellecchia; Felice Iasevoli; Annamaria Colao
Journal:  Front Neurosci       Date:  2015-04-20       Impact factor: 4.677

9.  Glucocorticoid Regulation of Food-Choice Behavior in Humans: Evidence from Cushing's Syndrome.

Authors:  Scott J Moeller; Lizette Couto; Vanessa Cohen; Yelena Lalazar; Iouri Makotkine; Nia Williams; Rachel Yehuda; Rita Z Goldstein; Eliza B Geer
Journal:  Front Neurosci       Date:  2016-02-05       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.